Recently, multiple studies have reported the pleiotropic cytokine activities of IL-33 in mediating Th2 immune responses 13, enhancing antitumoral/antiviral Th1 and CD8+ T cell immunity 14-17, activating and recruiting antigen-presenting cells 18, and promoting wound healing 19 in immune disorders and various cancers. This evidence concerns the gene IL33 and cancer.